Free analysis
Pick one stock you own. We run the full read on it.
Name the ticker, and the complete Returnolio analysis of that company lands in your inbox as a PDF, usually within minutes. No card, no trial, one per person.
Request your analysis
We cover just under a thousand of the world's larger listed companies. If yours is not one of them, the email says so honestly, and asking again with a different ticker costs you nothing.
What arrives, exactly.
The same pages a subscriber sees for the company, captured live and assembled into one PDF. These are real captures from the product:




- The company, in plain terms
- Logo, what the business actually is, where the money comes from, who runs it and how many people work there, before any number asks to be trusted.
- The score, taken apart
- The 0-100 headline and the five pillars under it: business quality, real economic profit after the cost of capital, price against fair value, momentum, and what insiders are doing.
- Fair value, shown working
- Which valuation method fits this business, the inputs it used, and how far the current price sits from the result.
- The price, this year
- The TradingView chart from the product, with the year-to-date move and 52-week range computed from our own price data, dated.
- The three statements
- Income statement, balance sheet and cash flow, plus growth and margins: revenue down to profit, what the company owns and owes, and where cash actually went.
- Where the money is made
- Revenue by business line and by region, so concentration has a chart instead of a guess.
- Who is buying their own stock
- Insider and congressional filings on the company, each with its date, so you can see how old every trade is.
- Related news, with links
- Recent coverage of the company, dated, every headline a link you can follow to its source.
- The AI read: strengths, risks, what to watch
- A written read produced only from our data on the company, typeset in the report and clearly marked as machine-written. It cannot browse the web and it does not speculate.
- Is it in our Top 10?
- A straight answer against the newest edition free accounts can read in full. Ten names a month, equal weight, held with our own money.
One thing the report is not: advice. It is the published research, assembled for one company. It does not know your situation, and nothing in it is a recommendation to buy or sell. The method behind every number is public, in the docs.
How it works, honestly.
You name the company. Ticker and email, nothing else.
The product does the work. The pipeline opens the company's live pages, the same ones a subscriber sees, and prints them into one PDF. Not a template with your ticker pasted in: if a section has nothing for your company, it is left out rather than padded.
It arrives, usually within minutes, from our real support address, where you can reply with questions and a person answers.
The five questions the report answers.
Every holding should be able to survive these. The report brings the evidence for the first and the fifth, and its AI summary names the next catalyst when the data has one; the second and third are judgments only you can make, and the report gives you the numbers to make them against.
What does this company actually earn money from?
Which assumption must remain true for my thesis to work?
What evidence would change my mind?
What is the next dated event worth reviewing?
When did I last check the underlying evidence rather than the price?
To see what skipping the fifth one costs, read what Tattooed Chef cost me.